Gestational Hypertension and Preeclampsia
2020/05/22 · 2,768 citations
Medicine · #Birth, Development, and Health #Gestational age #Gestational hypertension #Latin Americans #Maternal and fetal healthcare #Medicine #Obstetrics #Pediatrics #Preeclampsia #Pregnancy #Pregnancy and preeclampsia studies
paper · doi:10.1097/aog.0000000000003891
published in Obstetrics and Gynecology 135(6), e237-e260 (Lippincott Williams & Wilkins)
openalex publication_date 2020/05/22 · openalex created_date 2022/02/13 · openalex updated_date 2026/08/06
Abstract
Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2-8% of pregnancies globally (). In Latin America and the Caribbean, hypertensive disorders are responsible for almost 26% of maternal deaths, whereas in Africa and Asia they contribute to 9% of deaths. Although maternal mortality is much lower in high-income countries than in developing countries, 16% of maternal deaths can be attributed to hypertensive disorders (). In the United States, the rate of preeclampsia increased by 25% between 1987 and 2004 (). Moreover, in comparison with women giving birth in 1980, those giving birth in 2003 were at 6.7-fold increased risk of severe preeclampsia (). This complication is costly: one study reported that in 2012 in the United States, the estimated cost of preeclampsia within the first 12 months of delivery was 2.18 billion (1.03 billion for women and 1.15 billion for infants), which was disproportionately borne by premature births (). This Practice Bulletin will provide guidelines for the diagnosis and management of gestational hypertension and preeclampsia.
Citations
Cited by
- Tailored Prenatal Care Delivery for Pregnant Individuals
- Interpregnancy Interval After Stillbirth and Adverse Perinatal Outcomes
- Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications
- Pregnancy and the liver
- The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association
- Cardiovascular complications of pregnancy
- Assessing Retinal Thickness and Associations with Cognitive Function in Women with History of Preeclampsia
- Unravelling sex-specific differences in autosomal dominant polycystic kidney disease: a multiorgan perspective
- A Systematic Review of International Guidelines for Addressing Alcohol Use Disorder in Pregnancy
- Pharmacological and immunohistochemical characterization of dopamine D4 receptor in human umbilical artery and vein
- Safety of a trial of labor after cesarean in kidney and liver transplant recipients: A multicenter cohort study
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Cellular immune responses in the pathophysiology of preeclampsia
- Maternal Plasma Levels of MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 as Predictive Biomarkers of Preeclampsia
- Patient and provider perspectives of a new prenatal care model introduced in response to the coronavirus disease 2019 pandemic. [europepmc]
- Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). [europepmc]
- Prevalence of Hypertension Among Pregnant Women When Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines and Association With Maternal and Fetal Outcomes. [europepmc]
- Team-Based Care of Women With Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 1/5. [europepmc]
- Cellular immune responses in the pathophysiology of preeclampsia. [europepmc]
- The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia. [europepmc]
- Perinatal Outcomes of Two Screening Strategies for Gestational Diabetes Mellitus: A Randomized Controlled Trial. [europepmc]
- SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. [europepmc]
- Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension. [europepmc]
- NLRP3 Activation and Its Relationship to Endothelial Dysfunction and Oxidative Stress: Implications for Preeclampsia and Pharmacological Interventions. [europepmc]
- Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction. [europepmc]
- Using Machine Learning to Predict Complications in Pregnancy: A Systematic Review. [europepmc]
- Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications. [europepmc]
- Early prediction of preeclampsia in pregnancy with cell-free RNA. [europepmc]
- The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease. [europepmc]
- Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. [europepmc]
- Chronic Hypoxia in Ovine Pregnancy Recapitulates Physiological and Molecular Markers of Preeclampsia in the Mother, Placenta, and Offspring. [europepmc]
- 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension. [europepmc]
- Inflammation in Preeclampsia: Genetic Biomarkers, Mechanisms, and Therapeutic Strategies. [europepmc]
- A global view of hypertensive disorders and diabetes mellitus during pregnancy. [europepmc]
- Association Between Hypertensive Disorders of Pregnancy and Dementia: a Systematic Review and Meta-Analysis. [europepmc]
- Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. [europepmc]
- Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association. [europepmc]
- Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association. [europepmc]
- A Narrative Review on the Pathophysiology of Preeclampsia. [europepmc]
Related